SCHEDULE 13G//SEC Filing
KalVista Pharmaceuticals, Inc. SCHEDULE 13G
Accession 0000902664-26-000176
CIK 0001603466other
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 6:34 PM ET
Size
17.8 KB
Accession
0000902664-26-000176
Issuer
Point72 Asset Management, L.P.
CIK 0001603466
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001603466
Filing Metadata
- Form type
- SCHEDULE 13G
- Filed
- Jan 11, 7:00 PM ET
- Accepted
- Jan 12, 6:34 PM ET
- Size
- 17.8 KB